To Decrease Fatigue With Light Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
FIL Study on ABVD DD-DI as Upfront Therapy in HL.
- Status
- COMPLETED
- Phase
- PHASE3
Bergamo Lymphoid Cancer Registry
- Status
- RECRUITING
- Phase
- N/A
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Auto Stem Cell Transplant for Lymphoma Patients
- Status
- RECRUITING
- Phase
- PHASE2
Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Familial Investigations of Childhood Cancer Predisposition
- Status
- RECRUITING
- Phase
- N/A
A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
- Status
- COMPLETED
- Phase
- PHASE1
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)
- Status
- COMPLETED
- Phase
- PHASE1
Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery
- Status
- COMPLETED
- Phase
- NA
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
- Status
- COMPLETED
- Phase
- PHASE1
Genetic Study of Families With High Frequency of Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
- Status
- UNKNOWN
- Phase
- N/A
Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas
- Status
- TERMINATED
- Phase
- PHASE2